Rationale for IL-1beta targeted therapy for ischemia-reperfusion induced pulmonary and other complications in sickle cell disease.

Wanderer, Alan A

Wanderer, Alan A.

Affiliation

Wanderer AA; University of Colorado Health Sciences Center, Aurora, CO, USA. aw@aacmt.com

J Pediatr Hematol Oncol ; 31(8): 537-8, 2009 Aug.

Article in En | MEDLINE | ID: mdl-19636265

Subject(s)

Anemia, Sickle Cell/blood; Anemia, Sickle Cell/drug therapy; Hypertension, Pulmonary/blood; Hypertension, Pulmonary/drug therapy; Interleukin-1beta/antagonists & inhibitors; Interleukin-1beta/blood; Reperfusion Injury/blood; Reperfusion Injury/drug therapy; Adult; Anemia, Sickle Cell/complications; Anemia, Sickle Cell/physiopathology; Animals; Hemolysis; Humans; Hypertension, Pulmonary/etiology; Nitric Oxide/blood; Phenotype; Reperfusion Injury/etiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reperfusion Injury / Interleukin-1beta / Hypertension, Pulmonary / Anemia, Sickle Cell Type of study: Etiology_studies Limits: Adult / Animals / Humans Language: En Journal: J Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google